Hayasaka Naotaka 早坂尚貴

Researcher Number	00792665
Affiliation (Current)	2025: 札幌医科大学, 医学部, 研究員
Affiliation (based on the past Project Information) *help	2017 – 2023: 札幌医科大学, 医学部, 研究員
Review Section/Research Field	Principal Investigator Basic Section 53010:Gastroenterology-related Except Principal Investigator Tumor therapeutics
Keywords	Principal Investigator Immunotherapy / Gastric cancer / SMARCA4 / 発癌機序 / 薬剤耐性 / JAK-STAT / 細胞周期 / 化学療法 / STEAP1 / 食道癌 … More Except Principal Investigator … More 糖代謝特性 / ドラッグデリバリー / ドラッグデリバリーシステム / 大腸癌 Less

Development a novel immnunotherapy for gastric cancer by targeted SMARCA4Principal Investigator
- Principal Investigator
  
  早坂尚貴
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Sapporo Medical University
Analysis of pathological modification mechanism of esophageal cancer by STEAP1 for development of new treatmentPrincipal Investigator
- Principal Investigator
  
  Hayasaka Naotaka
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Sapporo Medical University
Development of a new treatment for colorectal cancer using the glucose metabolism characteristics.
- Principal Investigator
  
  Kato Junji
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Tumor therapeutics
- Research Institution
  Sapporo Medical University

All 2024 2023 2017

All Journal Article

[Journal Article] High-grade B-cell lymphoma, not otherwise specified, presenting as primary peritoneal lymphomatosis and successfully treated with dose-adjusted EPOCH-R2024
- Author(s)
  Fujimi Akihito、Nagamachi Yasuhiro、Yamauchi Naofumi、Onoyama Naoki、Hayasaka Naotaka、Matsuno Teppei、Koike Kazuhiko、Goto Yoshiro、Ihara Kohji、Kato Junji、Nishisato Takuji、Kawase Hiroshi、Yano Tomoyuki、Kanaseki Takayuki、Sugita Shintaro、Kobune Masayoshi
- Journal Title
  
  Journal of Clinical and Experimental Hematopathology
  
  Volume: 64 Issue: 1 Pages: 37-44
- DOI
  10.3960/jslrt.23044
- ISSN
  1346-4280, 1880-9952
- Language
  English
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K15047, KAKENHI-PROJECT-22K08509
[Journal Article] Pemphigus vulgaris as an immune-related adverse event in recurrent metastatic esophageal squamous cell carcinoma treated with ipilimumab plus nivolumab: a case report and literature review2023
- Author(s)
  Nakamura Hajime、Shionoya Aika、Arihara Yohei、Hayasaka Naotaka、Kubo Tomohiro、Usami Makoto、Sugita Shintaro、Uhara Hisashi、Takada Kohichi
- Journal Title
  
  Frontiers in Immunology
  
  Volume: 14
- DOI
  10.3389/fimmu.2023.1259071
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K15047
[Journal Article] Small molecule CP-31398 induces reactive oxygen species-dependent apoptosis in human multiple myeloma2017
- Author(s)
  Arihara Yohei、Takada Kohichi、Kamihara Yusuke、Hayasaka Naotaka、Nakamura Hajime、Murase Kazuyuki、Ikeda Hiroshi、Iyama Satoshi、Sato Tsutomu、Miyanishi Koji、Kobune Masayoshi、Kato Junji
- Journal Title
  
  Oncotarget
  
  Volume: 8 Issue: 39 Pages: 65889-65899
- DOI
  10.18632/oncotarget.19508
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K07178, KAKENHI-PROJECT-17H03599, KAKENHI-PROJECT-15K09482

1. Kato Junji (20244345)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
2. 高田弘一 (90398321)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
3. 大須賀崇裕 (40619714)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. 宮西浩嗣 (60372819)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. 在原洋平

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Hayasaka Naotaka 早坂尚貴

Research Projects

Research Products

Co-Researchers

Development a novel immnunotherapy for gastric cancer by targeted SMARCA4Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Analysis of pathological modification mechanism of esophageal cancer by STEAP1 for development of new treatmentPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of a new treatment for colorectal cancer using the glucose metabolism characteristics.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] High-grade B-cell lymphoma, not otherwise specified, presenting as primary peritoneal lymphomatosis and successfully treated with dose-adjusted EPOCH-R2024

Author(s)

Journal Title

DOI

ISSN

Language

Data Source

[Journal Article] Pemphigus vulgaris as an immune-related adverse event in recurrent metastatic esophageal squamous cell carcinoma treated with ipilimumab plus nivolumab: a case report and literature review2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Small molecule CP-31398 induces reactive oxygen species-dependent apoptosis in human multiple myeloma2017

Author(s)

Journal Title

DOI

Data Source

Hayasaka Naotaka 早坂 尚貴

Research Projects

Research Products

Co-Researchers

Development a novel immnunotherapy for gastric cancer by targeted SMARCA4Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Analysis of pathological modification mechanism of esophageal cancer by STEAP1 for development of new treatmentPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of a new treatment for colorectal cancer using the glucose metabolism characteristics.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] High-grade B-cell lymphoma, not otherwise specified, presenting as primary peritoneal lymphomatosis and successfully treated with dose-adjusted EPOCH-R2024

Author(s)

Journal Title

DOI

ISSN

Language

Data Source

[Journal Article] Pemphigus vulgaris as an immune-related adverse event in recurrent metastatic esophageal squamous cell carcinoma treated with ipilimumab plus nivolumab: a case report and literature review2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Small molecule CP-31398 induces reactive oxygen species-dependent apoptosis in human multiple myeloma2017

Author(s)

Journal Title

DOI

Data Source

Hayasaka Naotaka 早坂尚貴